Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
SEI International Equity F (SIT) SEITX
- NAV / 1-Day Return 12.56 / +0.72 %
- Total Assets 3.9 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.100%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 100,000
- Status Open
- TTM Yield 1.93%
- Turnover 87%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:17 PM GMT+0
Morningstar’s Analysis SEITX
Will SEITX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 13.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Roche Holding AG | 2.48 | 97.0 Mil | Healthcare |
Novo Nordisk A/S Class B | 2.36 | 92.6 Mil | Healthcare |
Shell PLC | 1.31 | 51.3 Mil | Energy |
Cash | 1.12 | 43.8 Mil | Cash and Equivalents |
Reckitt Benckiser Group PLC | 1.10 | 43.1 Mil | Consumer Defensive |
UBS Group AG | 1.07 | 41.8 Mil | Financial Services |
SEI Government Institutional (SDIT) | 1.04 | 40.7 Mil | Cash and Equivalents |
ING Groep NV | 0.99 | 38.9 Mil | Financial Services |
Sanofi SA | 0.99 | 38.8 Mil | Healthcare |
CaixaBank SA | 0.96 | 37.5 Mil | Financial Services |